Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 11/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.75 |
| ▸ | HTT | P42858 | 2/20 | 0.72 |
| ▸ | TSHR | P16473 | 1/20 | 0.72 |
| ▸ | HPGD | P15428 | 2/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | CASP1 | P29466 | 1/20 | 0.62 |
| ▸ | CASP7 | P55210 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | RAD52 | P43351 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | GPR174 | Q9BXC1 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12135872 | 0.86 | KDM4E (0.74) | GAAALDH1A1KDM4EHTTTSHR | |
| SCHEMBL15057001 | 0.86 | ALDH1A1 (0.57) | GAAALDH1A1KDM4EHTTTSHR | |
| SCHEMBL10046487 | 0.84 | GAA (0.73) | GAAALDH1A1KDM4EHTTTSHR | |
| SCHEMBL15056854 | 0.83 | GAA (0.78) | GAAALDH1A1KDM4EHTTTSHR | |
| SCHEMBL30545905 | 0.81 | GPR174 (0.75) | GAAALDH1A1KDM4EHTTHSD17B10 | |
| SCHEMBL7820721 | 0.81 | GPR174 (0.75) | GAAALDH1A1KDM4EHTTHSD17B10 | |
| SCHEMBL15056340 | 0.81 | GAA (0.69) | GAAALDH1A1KDM4EHTTTSHR | |
| SCHEMBL3324154 | 0.79 | KDM4E (0.75) | GAAALDH1A1KDM4EHTTTSHR | |
| SCHEMBL15057460 | 0.79 | GAA (0.72) | GAAALDH1A1KDM4EHTTTSHR | |
| SCHEMBL7817352 | 0.79 | MAPT (0.71) | GAAALDH1A1KDM4EHTTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2794572-B1 | ACRIDINEDIONE DERIVATIVES FOR TREATING PIGMENTATION DISORDERS AND AGEING OF THE SKIN | PIERRE FABRE DERMO COSMÉTIQUE (FR) | 2016-08-03 | — | — | EP | claimed |
| US-20140348768-A1 | ACRIDINEDIONE DERIVATIVES FOR TREATING PIGMENTATION DISORDERS AND AGEING OF THE SKIN | PIERRE FABRE DERMO COSMETIQUE (FR) | 2014-11-27 | — | — | US | claimed |
| EP-2794572-A1 | ACRIDINEDIONE DERIVATIVES FOR TREATING PIGMENTATION DISORDERS AND AGEING OF THE SKIN | Pierre Fabre Dermo-Cosmétique (FR) | 2014-10-29 | — | — | EP | claimed |
| WO-2013093019-A1 | ACRIDINEDIONE DERIVATIVES FOR TREATING PIGMENTATION DISORDERS AND AGEING OF THE SKIN | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2013-06-27 | — | — | WO | claimed |
| US-6265127-B1 | 1, 4-dihydrophyridine charge control agents for electrostatographic toners and developers | EASTMAN KODAK COMPANY | 2001-07-24 | — | — | US | claimed |
| US-9493421-B2 | Acridinedione derivatives for treating pigmentation disorders and ageing of the skin | PIERRE FABRE DERMO COSMETIQUE (FR) | 2016-11-15 | — | — | US | disclosed |
| US-9493421-B2 | Acridinedione derivatives for treating pigmentation disorders and ageing of the skin | PIERRE FABRE DERMO COSMETIQUE (FR) | 2016-11-15 | — | — | US | disclosed |
| US-9493421-B2 | Acridinedione derivatives for treating pigmentation disorders and ageing of the skin | PIERRE FABRE DERMO COSMETIQUE (FR) | 2016-11-15 | — | — | US | disclosed |
| EP-2794572-B1 | ACRIDINEDIONE DERIVATIVES FOR TREATING PIGMENTATION DISORDERS AND AGEING OF THE SKIN | PIERRE FABRE DERMO COSMÉTIQUE (FR) | 2016-08-03 | — | — | EP | disclosed |
| EP-2794572-B1 | ACRIDINEDIONE DERIVATIVES FOR TREATING PIGMENTATION DISORDERS AND AGEING OF THE SKIN | PIERRE FABRE DERMO COSMÉTIQUE (FR) | 2016-08-03 | — | — | EP | disclosed |
| US-20140348768-A1 | ACRIDINEDIONE DERIVATIVES FOR TREATING PIGMENTATION DISORDERS AND AGEING OF THE SKIN | PIERRE FABRE DERMO COSMETIQUE (FR) | 2014-11-27 | — | — | US | disclosed |
| US-20140348768-A1 | ACRIDINEDIONE DERIVATIVES FOR TREATING PIGMENTATION DISORDERS AND AGEING OF THE SKIN | PIERRE FABRE DERMO COSMETIQUE (FR) | 2014-11-27 | — | — | US | disclosed |
| US-20140348768-A1 | ACRIDINEDIONE DERIVATIVES FOR TREATING PIGMENTATION DISORDERS AND AGEING OF THE SKIN | PIERRE FABRE DERMO COSMETIQUE (FR) | 2014-11-27 | — | — | US | disclosed |
| EP-2794572-A1 | ACRIDINEDIONE DERIVATIVES FOR TREATING PIGMENTATION DISORDERS AND AGEING OF THE SKIN | Pierre Fabre Dermo-Cosmétique (FR) | 2014-10-29 | — | — | EP | disclosed |
| WO-2013093019-A1 | ACRIDINEDIONE DERIVATIVES FOR TREATING PIGMENTATION DISORDERS AND AGEING OF THE SKIN | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2013-06-27 | — | — | WO | disclosed |
| WO-2013093019-A1 | ACRIDINEDIONE DERIVATIVES FOR TREATING PIGMENTATION DISORDERS AND AGEING OF THE SKIN | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2013-06-27 | — | — | WO | disclosed |
| US-6265127-B1 | 1, 4-dihydrophyridine charge control agents for electrostatographic toners and developers | EASTMAN KODAK COMPANY | 2001-07-24 | — | — | US | disclosed |
| EP-1109070-A2 | 1,4-Dihydropyridine charge control agents for electrostatographic toners and developers | EASTMAN KODAK COMPANY (US) | 2001-06-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140348768-A1 | ACRIDINEDIONE DERIVATIVES FOR TREATING PIGMENTATION DISORDERS AND AGEING OF THE SKIN | TYR, PAH, AKR1C3 | GAA 2692/4885ALDH1A1 118/4885KDM4E 2348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.